Cargando…
Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor Immunity
As the leading cause of cancer-related death, hepatocellular carcinoma (HCC) threatens human health and limited treatments are available to cure the disease efficiently and effectively. The particularly immunotolerant environment of the liver lowers the efficacy of current therapies in patients with...
Autores principales: | Jia, Wentao, Wang, Lina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305542/ https://www.ncbi.nlm.nih.gov/pubmed/32595757 http://dx.doi.org/10.1155/2020/9843486 |
Ejemplares similares
-
The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment
por: Jia, Wentao, et al.
Publicado: (2021) -
Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma
por: Xi, Sheng-Yan, et al.
Publicado: (2018) -
Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma
por: Wei, Lai, et al.
Publicado: (2022) -
Application of immune checkpoint targets in the anti-tumor novel drugs and traditional Chinese medicine development
por: Wang, Yuli, et al.
Publicado: (2021) -
Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma
por: Li, Yuyao, et al.
Publicado: (2022)